Flt3-mutated Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Flt3-mutated Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-01-12FDA Approved: XOSPATA — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for XOSPATA (gilteritinib) submitted by Astellas Pharma US, Inc.